❌

Reading view

There are new articles available, click to refresh the page.

South Africa Runs Out of Insulin Pens as Global Supply Shifts to Weight-Loss Drugs

The shortage highlights a widening gulf in the standard of care for people with diabetes, most of whom live in low-income countries.

Β© Jean-Francois Monier/Agence France-Presse β€” Getty Images

A high-speed production line of insulin at a Novo Nordisk factory. The company said it would continue to supply insulin in vials to South Africa, where more than four million people live with diabetes.

Doctors Test the Limits of What Obesity Drugs Can Fix

β€œObesity first” doctors say they start with one medication, to treat obesity, and often find other chronic diseases, like rheumatoid arthritis, simply vanish.

Β© M. Scott Brauer for The New York Times

With Wegovy, one of the new obesity drugs, Lesa Walton not only lost more than 50 pounds; her arthritis cleared up and she no longer needed pills to lower her blood pressure, she said.

FDA Panel Rejects Use of MDMA for Treatment of PTSD

An independent group of experts expressed concerns that the data from clinical trials did not outweigh risks for treatment of post-traumatic stress disorder.

Β© Travis Dove for The New York Times

A dose of MDMA from the MAPS Public Benefit Corp., which is now renamed as Lykos Therapeutics, a for-profit company whose studies the F.D.A. is analyzing.
❌